Category Archives: Technology

August 4th, 2021

5:00 PM - 6:00 PM PDT

Join the San Diego Paralegal Association (SDPA) and the ACEDS Orange County Chapter for an eDiscovery Summer Refresher Virtual Conference.

About this event

Session One: Applying Technology to Address Discovery Challenges Today and Tomorrow

Presented by Doug Austin from eDiscovery Today. Introduction by Marla Mohr, President of ACEDS Orange County and Legal Technology Consultant

*Attendees are eligible for One Hour of CA MCLE - Courtesy of San Diego Paralegal Association.

In todays world of dramatically increased remote work due to the pandemic, growing data privacy concerns with GDPR, CCPA and other data privacy legislation, increase in harassment claims with #metoo and rising corporate malfeasance concerns, organizations have more challenges than ever that require the application of discovery technology and workflows even if those challenges never lead to litigation. This session will discuss the drivers and challenges facing organizations today to leverage technology and best practices to address todays evolving discovery needs. Topics include:

View original post here:

[Virtual Conference] eDiscovery Summer Refresher 2.0 - Session One: Applying Technology to Address Discovery Challenges Today and Tomorrow - August...

BLOOMINGTON, Minn.--(BUSINESS WIRE)--SkyWater Technology (NASDAQ: SKYT) announced that its Board of Directors has approved $56 million in strategic capital investments to expand the capacity and capabilities of its Minnesota facility and to accelerate the companys entry into the 200 mm GaN market.

These strategic investments evidence our commitment to our customers to co-create emerging technologies and help ensure we are in position to deliver long-term value to our shareholders, said Thomas Sonderman, president and CEO of SkyWater. We believe our investment in GaN technologies which expand possibilities for next generation microelectronics enhances SkyWaters position for leadership in the aerospace and defense, industrial and automotive markets. As recently noted in the White House 100 Day Supply Chain Review, there is a significant need for a U.S.-based foundry to offer technology services for GaN. We firmly believe SkyWater is that foundry.

In connection with its upcoming earnings webcast on August 4, 2021, the company also today announced selected preliminary financial results for the second quarter ended July 4, 2021.

For the second quarter ended July 4, 2021, the company expects to report net sales of $41.0 to $41.5 million, a net loss attributable to shareholders of $8.0 to $7.0 million, and Adjusted EBITDA of $(1.5) to $(0.5) million. Preliminary net sales, excluding tool sales, grew between 18% to 20% compared to first quarter 2021. Total preliminary net sales increased between 33% to 35% compared to second quarter 2020.

SkyWater accomplished much in the second quarter, including our initial public offering. This achievement is a great testament to our team members, customers and partners. In the midst of this, we were able to deliver significant sales growth, said Steve Manko, SkyWater CFO.

During the second quarter, SkyWaters other accomplishments include:

Investments in advanced packaging and RH90 are anticipated to be significant long-term growth drivers for the company but are a near-term headwind to profitability.

I am very pleased with our ATS pipeline growth as the industrys awareness of SkyWaters TaaS offering continues to build, said Sonderman. There is strong demand in the semiconductor market for a U.S. investor-owned pure play foundry with unique manufacturing capabilities. We believe our strengthening fundamentals and TaaS business model provide a solid foundation for long-term performance in our targeted end markets.

Selected preliminary financial results:

Second Quarter Ended July 4, 2021

Amounts in USD millions

Low

High

Net Sales

$41.0

$41.5

Net loss attributable to SkyWater Technology

$(8.0)

$(7.0)

Adjusted EBITDA

$(1.5)

$(0.5)

A reconciliation between historical GAAP and non-GAAP information is contained in the tables below in the section titled Non-GAAP Financial Measures.

The preliminary financial results set forth above are based solely on currently available information which is subject to change. The companys actual results for the second quarter ended July 4, 2021 may vary from these preliminary financial results and will not be finalized until after the date of this press release.

SkyWater has not provided quarterly or full year outlook for net sales or earnings because these estimates are difficult to predict on a forward-looking basis due to certain factors that are materially significant to SkyWaters ability to accurately forecast certain items that are out of its control and/or cannot be reasonably projected.

The company intends to report actual second quarter fiscal 2021 financial results following the close of the market on Tuesday, August 3, 2021. The following morning, management will host a webcast to discuss its business and financial results.

SkyWater Technology Second Quarter Fiscal 2021 Earnings WebcastWhen: Wednesday, August 4, 2021Time: 9:00 a.m. CT (10:00 a.m. ET)Live Webcast: https://ir.skywatertechnology.com

An archived webcast will be available on SkyWater Technologys Investor Relations page, https://ir.skywatertechnology.com.

About SkyWater TechnologySkyWater is a U.S.-owned and U.S.-based pure play semiconductor foundry and is a DOD-accredited Trusted supplier, specializing in custom technology development services, volume manufacturing and advanced packaging capabilities. Through its Technology Foundry model, SkyWaters world-class operations in Bloomington, Minnesota and Kissimmee, Florida provide unique processing capabilities to enable quality production and advanced packaging for mixed-signal CMOS, power, rad-hard and ROIC solutions. SkyWaters Advanced Technology Services empower development of superconducting and 3D ICs, along with carbon nanotube, photonic and MEMS devices. The company serves customers in growing markets such as aerospace & defense, automotive, biomedical, cloud & computing, consumer, industrial and IoT. Please visit http://www.skywatertechnology.com/ for more information.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements that are based on the Companys current expectations or forecasts of future events, rather than past events and outcomes, and such statements are not guarantees of future performance. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including information or predictions concerning the Companys future business, results of operations, financial performance, plans and objectives, competitive position, market trends, and potential growth and market opportunities. In some cases, you can identify forward-looking statements by words such as intends, estimates, predicts, potential, continues, anticipates, plans, expects, believes, should, could, may, will, targets, projects, seeks or the negative of these terms or other comparable terminology.

Forward-looking statements are subject to risks, uncertainties and assumptions, which may cause the Companys actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Key factors that could cause the Companys actual results to be different than expected or anticipated include, but are not limited to: our goals and strategies; our future business development, financial condition and results of operations; our ability to continue operating our sole semiconductor foundry at full capacity; our ability to appropriately respond to changing technologies on a timely and cost-effective basis; our customer relationships and our ability to retain and expand our customer relationships; our ability to accurately predict our future revenues for the purpose of appropriately budgeting and adjusting our expenses; our ability to diversify our customer base and develop relationships in new markets; our expectations regarding dependence on our largest customer; the performance and reliability of our third-party suppliers and manufacturers; our ability to control costs, including our operating and capital expenses; the size and growth potential of the markets for our solutions, and our ability to serve and expand our presence in those markets; the level of demand in our customers end markets; our ability to attract, train and retain key qualified personnel; adverse litigation judgments, settlements or other litigation-related costs; changes in trade policies, including the imposition of tariffs; our ability to raise additional capital or financing; our ability to accurately forecast demand; the impact of the COVID-19 pandemic on our business, results of operations and financial condition; the impact of the COVID-19 pandemic on the global economy; our ability to maintain compliance with certain U.S. Government contracting requirements; regulatory developments in the United States and foreign countries; our ability to protect our intellectual property rights; and other factors discussed in the Risk Factors section of the prospectus the Company filed with the SEC on April 22, 2021 and in other documents that the Company files with the SEC, which are available at http://www.sec.gov. The Company assumes no obligation to update any forward-looking statements, which speak only as of the date of this press release.

SKYT-IR

Non-GAAP Financial MeasuresThe following table presents a reconciliation of net loss to adjusted EBITDA, our most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.

Adjusted EBITDAAdjusted EBITDA is not a financial measure determined in accordance with U.S. GAAP. We define adjusted EBITDA as net income or loss before interest expense, income tax provision (benefit), depreciation and amortization, equity-based compensation and certain other items that we do not view as indicative of our ongoing performance, including fair value changes in contingent consideration, fair value changes in warrants and management fees.

We believe adjusted EBITDA is a useful performance measure because it allows for an effective evaluation of our operating performance when compared to our peers, without regard to our financing methods or capital structure. We exclude the items listed above from net income or loss in arriving at adjusted EBITDA because these amounts can vary substantially within our industry depending upon accounting methods and book values of assets, capital structures and the method by which the assets were acquired. Adjusted EBITDA should not be considered as an alternative to, or more meaningful than, net income determined in accordance with U.S. GAAP. Certain items excluded from adjusted EBITDA are significant components in understanding and assessing a companys financial performance, such as a companys cost of capital and tax structure, as well as the historic costs of depreciable assets, none of which are reflected in adjusted EBITDA. Our presentation of adjusted EBITDA should not be construed as an indication that our results will be unaffected by the items excluded from adjusted EBITDA. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items. Accordingly, the exclusion of these items and other similar items in our non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual, unless otherwise expressly indicated.

July 4, 2021

July 4, 2021

Low

High

In USD Millions

Net loss attributable to SkyWater Technology, Inc.

$

(8.0

)

$

(7.0

)

Interest expense

0.9

1.0

Income tax benefit

(3.6

)

(4.3

)

Depreciation and amortization

6.9

6.9

EBITDA

(3.8

)

(3.4

)

Paycheck Protection Program loan forgiveness

(6.5

)

(6.5

)

Corporate conversion and initial public offering related costs (1)

1.4

1.5

SkyWater Florida start-up costs (2)

0.4

0.5

Management transition expense (3)

0.4

0.4

Fair value changes in contingent consideration (4)

(1.0

)

(0.9

)

Equity-based compensation (5)

6.7

6.8

Original post:

SkyWater Technology to Strategically Invest $56 Million in Capacity Expansion and Gallium Nitride Technology - Business Wire

Guanajuato/Mexico, Sevilla/Spain, July 20th 2021.- Fortune Growers BB #:192013, a leading broccoli producer in Mexico, and ec2ce, an agriculture technology company based in Spain, announced today their collaboration to deploy advanced predictive analytics in the broccoli sector in Mexico to improve operations by maximizing high quality products for the export market.

The prediction of broccoli productivity and cycle-optimum harvest timing will improve commercialization of vegetable production from different farms and varieties planted, as well as harvesting and logistics operations to match supply and demand with superior food safety compliance.

Another project being deployed in the state of Guanajuato is for predictive pest and disease control, which allows farmers to diminish crop damage through data-informed preventive actions, instead of solely relying on reactive scouting practices.

The predictive pest and disease system from ec2ce is calibrated with historical data from monitoring and scouting, updated with geolocated climatic and satellite indexes, and is able to provide actionable information for the farmer to prevent aggressive pest evolution.

This strategic alliance with ec2ce represents an extraordinary opportunity to increase the digitalization of our farms and improve the decision-making process in our operations, said Luis Solarte, president of Fortune Growers.

Fortune Growers Mexico operations have a proven process for growing and sourcing vegetables for over 15 years. We efficiently manage an optimal cold-chain for exportation in addition to direct transportation to facilities with no cold-chain breakage, providing a reliable year-round availability thanks to a complete and truly vertically integrated supply chain.

The strategic focus of Fortune Growers is to integrate different technologies for optimizing safety, productivity, and sustainability of vegetable production. In addition to ec2ce, Fortunes strategy includes partnerships with Bayer, Sakata, AgTools, and Famous Software, resulting in state-of-the-art, full tech solutions that are piloted, scaled, and deployed across its grower network and operations.

The goal of the company is to become the leading vegetable producer and distributor from Mexico into high value markets in the US and Canada, explained Mr. Solarte.

According to Pedro Carrillo, CEO of ec2ce, this partnership is a very important step in the strategic roadmap of the company entering in the Mexican specialties agriculture sector, Fortune Growers demonstrate a visionary strategy for managing the complete supply chain to provide clients with the best quality product on time.

The Spanish technological company is initiating its operations in Mexico and North America after demonstrating a successful track record in the past 7 years with leading vegetable and fruit companies in Europe, from multinational seed companies to major specialties producers and processors.

This is a great opportunity for us to demonstrate the value that data analytics and predictive analytics provides to decision makers in companies who care about quality food and optimum distribution to match supply and demand, said Mr. Carrillo.

Additionally, our company is able to provide predictive pest and disease management systems which are able to anticipate the pest pressure and prevent the damage occurred at farms. This system works with the same predictive analytics technology but feeding pest monitoring data bases integrated with weather, satellite indexes, and crop development. ec2ce and Fortune Growers are already in conversations with the Comit Estatal de Sanidad vegetal de Guanajuato (Cesaveg) to prepare a Predictive Pest and Disease Predictive Management System for all veggies producers affected by the Plutella xylostella pest in the region.

Luis Solarte highlights that Fortune Growers is working directly with producers, companies, government agencies and other organizations to accelerate and deepen the positive impact the company can make. Fortune Growers is growing its partnerships in the change process, where we (Fortune Growers) have invested directly in the continuous improvement of agricultural production with interest-free financing programs, food safety support services, a full range of training offerings, technical support, etc. using all possible financial resources to continue our mission of social and economic development in the region.

Fortune Growers has expanded and diversified the markets and we continue to work on optimizing this entire chain, seeking efficacy and efficiency to achieve the highest levels of sustainability, zero waste, and the highest levels of safety.

Fortune Growers has initiated a broccoli pilot program with its small and medium-size farmers in the state of Guanajuato. This initiative, now supported by ec2ce can be replicated and applied for all vegetable products with over fifty producers in the Fortune Growers network.

Fortune Growers continues to grow and expand its network across Mexico and is committed to promoting and supporting small and medium farmers, supporting the implementation of a complete program that includes commercialization, marketing, legal support, regulatory compliance, business administration, logistics, relations with institutions in the countries involved, strategic alliances with suppliers, financial structuring, risk management and brand positioning.

Fortune Growers model combines the Secretariat of Agriculture, the National Agro-Alimentary Health, Safety and Quality Service (SENASICA) public policies and Contamination Risk Reduction Systems (SRRC) with US FDA requirements to ensure full compliance from multiple concurring perspectives. Under this model, Fortune Growers verifies that all products satisfy U.S. Good Agricultural Practices and contribute to a sustainable network of farmers.

About Fortune GrowersWith over 75 years of combined produce experience, Fortune Growers is a true innovator in the produce industry and takes great pride in being on the cutting edge when it comes to Growing, Sourcing, Food Safety and Produce Logistics across North America. With a multinational growing approach, Fortune Growers consistently supplies the freshest and highest quality produce on a year-round basis. Fortune Growers is among one of the largest growers of Broccoli in Mexico, but also grows large volumes of Carrots, Cabbage, Celery, Green Onions, Cauliflower, Lettuce and a variety of other commodities at their growing cooperatives in California, Mexico and Canada. Since Fortune Growers customers are working directly with a premier grower/shipper, they have direct access to a consistent supply of high-quality produce. This eliminates additional markups, and reduces the time involved so that our customers receive the freshest produce possible.

About ec2ceec2ce operates a proprietary AI-powered engine with a suite of add-on services that helps farmers, processors, and wholesalers to make smarter decisions to improve return and sustainability. ec2ces innovative mathematical solutions provide novel insights and best-in-class predictive analytics to customers to anticipate better decisions affecting profitability and sustainability in food supply chain, such as seeds selection and performance forecasting, productivity forecasting, predictive pest management, and optimization of inputs. ec2ce has operations and recurrent customers in Europe and LatAm, with targeted markets in expanding operations in Mexico and California. ec2ce is one of the startups highlighted by different analysts, as CB Insights, The Mixing Bowl, Better Food Ventures, and Marketsandmarkets, as a key player in predictive modelling within the ag-tech arena.

Link:

Fortune Growers to deploy predictive analytics technology in vegetable supply chain Produce Blue Book - Produce Blue Book

NEW YORK, July 27, 2021 /PRNewswire/ -- InsideQuantumTechnology.com, a media property of 3DR Holdings announced today the worldwide publication of Quantum Tech Pod -iqtpodcast.com - the first podcast on the topic of Quantum Technology/Computing. The premiere episode features host Chris Bishop in discussion with researcher Lawrence Gasman, founder of Inside Quantum Technology news, and chairperson of the international series of hybrid conferences including IQT Fall (New York), IQT Spring (San Diego), IQT Asia Pacific and IQT the Hague.

Alan M. Meckler, CEO of 3DR Holdings stated that, "the launch of Quantum Tech Pod is an exciting dimension to our coverage of the rapidly growing field of Quantum Technology and Computing." Meckler adds that, "presently 3DR Holdings is the only organization worldwide offering daily news, research and consulting, conferences and podcasts and that additional services are in the offing."

3DR Holdings currently streams the 3DPod as part of its3DPrint.comfamily. Started in 2019, the 3D Pod now features more than 50 episodes featuring some of the biggest names in the 3D Printing industry. It is expected that Quantum Tech Pod will accomplish something similar forInsideQuantumTechnology.com

The first episode of Quantum Tech Pod is available on iTunes, Spotify and InsideQuantumTechnology.com.

About 3DR Holdings3DR Holdings is an international tech media organization based in New York City that produces events, publishes daily news, offers research/consulting and broadcasts podcasts in the fields of Quantum Technology and Computing and 3D Printing. For additional information, please visit https://3drholdings.com

Contact:[emailprotected] 917-403-6300

Press contact: Barry Schwartz, [emailprotected], 212-677-8700 ext. 118

SOURCE Inside Quantum Technology

http://InsideQuantumTechnology.com

Originally posted here:

Inside Quantum Technology Announces Launch of QUANTUM TECH POD, the First Podcast Covering the Field of Quantum Computing - PRNewswire

DALLAS, July 27, 2021 /PRNewswire/ -- In this post- COVID world, making buildings safer is a top priority for educators, companies and builders nationwide. To help meet that demand, CASPR Grouptoday announced a distributor venture with Dakota Safety, a leading national distributor of building safety products, to help bring CASPR's disinfection technology to their customers nationwide.

"Safety is our first, middle and last name. We pride ourselves on being a value-added distributor that can help our customers grow their businesses with the best products in the market," said Andrew Miller, Founder and President, Dakota Safety. "We've brought on the CASPR Group's line of products because we believe they offer tremendous value for businesses and spaces needing continuous surface and air disinfection. Combining CASPR's strong product line and proven technology with Dakota Safety's 10-year track record of delivering safety products in the built world, you have an absolutely winning solution."

"This is a natural fit. We are both passionate about helping businesses bring back their employees and customers to safe buildings," said Dr. Suchy, co-founder and CTO of the CASPR Group. "Our disinfection technology has been proven to kill 99.99% of SARS-CoV-2 viruseswithin 24 hours, according to a study by the University of Wisconsin, and this new agreement will ensure that we can further expand our solutions and help together get companies back to work."

Unlike disinfection processes that use an episodic ultraviolet (UV) light or harmful chemicals, CASPR's technology uses a proprietary Natural Catalytic Converter (NCC) process to naturally extract oxygen and moisture from ambient air and then produce and safely deliver continuous trace levels of hydrogen peroxide (H2O2) to disinfect indoor spaces. The result is an automated and continuous reduction of air and surface viruses and bacteria in a way that is safe for use in spaces occupied with people and pets, and with no need to modify existing custodial processes.

About CASPR Group

CASPR Group is on a mission to make the world indoors a better place. As the leader in smart environmental indoor technology, our solutions work to ensure the indoor air we breathe is the healthiest it can be, living out our well-being and our performance in the process. Our award-winning continuous disinfection technology based on photocatalysis, creates safe levels of hydrogen peroxide to attack viruses, bacteria, and mold at the molecular level. The innovative technology is completely automated and does not require an operator to work. The company is based in Addison, Texas. To learn more, visit http://www.casprgroup.com.

About Dakota Safety

Dakota Safety are the champions of workplace safety through specialized safety and guarding solutions. They have established a reputation of creating innovative and cost-effective safety solutions for clients of all sizes and in numerous industries across North America. Dakota Safety's employee specialists are dedicated to making the workplace a safer environment. The company is based in Saint Paul MN. To learn more, visit http://www.dakotasafety.com

Media Contact

Malikka Smith

CASPR Group

(214) 396-3314

[emailprotected]

SOURCE CASPR Group

View post:

Dakota Safety Adds CASPR Group's Disinfection Technology to Their Lineup - PRNewswire

Potential for Affordable COVID-19 Immunization Coverage in Underserved African Countries

Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreement

Provides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III clinical trials

Establishes co-development basis for researching, developing and manufacturing multiple other C1 produced vaccines in addition to DYAI-100

Intends to reduce African dependence on foreign vaccine suppliers

Combined with previous C1 COVID-19 vaccine collaborations in India and South Korea (including Southeast Asia), this agreement further supports the potential for C1 produced COVID-19 immunization coverage to more than 40% of the worlds population

JUPITER, Fla., July 27, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Dyadic, we, us, our, or the Company) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve access to biologic vaccines and drugs at flexible commercial scales, today announced it signed a COVID-19 vaccine technology transfer and licensing agreement (the Rubic Agreement) with the Rubic Consortium (Rubic), a South African-based company whose mission is to develop a South African-based solution for the discovery, development, evaluation and manufacture of high-quality, cost-effective vaccines for distribution primarily to the African markets.

Rubic was founded by a consortium of public health, medical, academia, vaccine technology, technology transfer and economic sector experts interested in addressing the regions specific challenges related to vaccine availability and affordability. Overseeing the implementation of the technologies introduced or developed is a team of leading academics directed by the University of the Witwatersrand, Johannesburg (Wits) academic team, with the support of Wits Health Consortium (WHC), a wholly owned company of Wits.

Story continues

Rubics strategic vision includes:

Establishing a vaccine research hub and center for higher learning and R&D facilities.

Establishing a vaccine manufacturing unit with the infrastructure, processing operations and capabilities for the manufacture and distribution of high-quality vaccines throughout the African continent.

As recently noted by the World Health Organization, there are currently fewer than 10 African manufacturers with vaccine production capacity based in 5 countries with no immediate readiness to repurpose facilities for large scale production in the event of an emergency. The need to quickly acquire and commercialize technology and manufacturing capabilities, which addresses the infrastructure necessary to deploy vaccinations for broad populations affordably and timeously has never been a more strategic imperative of African nations than today, said Shabir Madhi, professor of vaccinology, Dean Faculty of Health Sciences at the University of the Witwatersrand, Johannesburg, who is leading COVID-19 vaccine trials in South Africa. Professor Madhi continued, We expect that the high yields and low costs of the C1 cell line have the potential to provide affordable solutions for multiple diseases that African countries are likely to benefit from.

Michael Tarnok Chairman of the Board stated, Global health professionals have long known of the varying levels of health services available around the world. However, the COVID-19 global pandemic has specifically highlighted the inequities in vaccination rates. We believe that the efficiency and flexibility of the C1 expression system can reduce the cost and increase worldwide access to vaccines and biologic medicines and contribute to improving global health equity. With anticipated clinical successes, together with our collaborators, we expect our C1 manufacturing platform will be positioned to provide affordable COVID-19 immunization to more than 40% of the global population, including significant areas that have been historically underserved. In addition, this collaboration will also prepare Africa for potential new pandemics and help to address multiple other existing disease states. Further, Dyadic is currently in discussions with other countries that may further expand the Companys global coverage.

Some of the highlights of the Rubic Agreement are as follows:

Rubic will be licensed to utilize the C1 Platform for the research, development, regulatory approval, manufacture, launch, marketing, and commercialization of a COVID-19 vaccine(s) that may be manufactured in South Africa and sold in multiple countries on the African continent.

Rubic will be responsible for presenting the proposed design and funding of a Phase II clinical trial within a specified timeframe of the executed technology transfer and licensing agreement.

Rubic, subject to certain terms and conditions, may utilize the C1 platform to conduct research and development, conduct pre-clinical studies and clinical studies and commercialize COVID-19 and other vaccines.

Rubic will initiate a detailed review of locations in South Africa suitable for use as a cGMP Source for CoV-2 bulk materials at a facility owned or controlled by Rubic.

Dyadic will facilitate technology transfer of the C1 Platform to Rubic through the completion of clinical trials.

Other than as provided by the Rubic Agreement, Dyadic will have the exclusive license and right to make, have made, use, sell, offer to sell, market, and commercialize any COVID-19 commercial product arising from joint development with Rubic.

The agreement provides Rubic with the ability to conduct research and development activities with multiple other C1 produced vaccines in addition to DYAI-100. Dyadic will maintain and own all background and foreground intellectual property rights relating to the C1 platform, derived from any and all research and development as a result of the project.

Dyadic will provide certain technical tools and assistance to Rubic, in addition to providing certain genetically modified and engineered C1-cells for the discovery, development and manufacturing of novel SARS-CoV-2 RBD variant of concern antigens, potentially leading to a therapeutic and/or prophylactic COVID-19 vaccine(s) which address SARS-CoV-2 variants of concern.

If Dyadics COVID-19 (i.e., DYAI-100) Phase I vaccine clinical trial is successfully completed, starting with Phase II, all costs for the development, regulatory approval, manufacturing, launch and/or commercialization of a COVID-19 commercial product in the Territory as defined in the Rubic Agreement will be borne by Rubic.

Rubic and its authorized sublicensees will pay to Dyadic a licensing fee equal to (i) a percentage of the sales of the applicable COVID-19 commercial product(s) or a per vaccine fee per dose (as defined in the agreement).

About The Rubic Consortium

The Rubic Consortium is made up of promoters of the project representing public health, medical, academia, vaccine technology, technology transfer and economics sectors. Development and the implementation of vaccine technologies will be overseen by leading academics directed by the University of the Witwatersrand, Johannesburg (Wits) academic team, with the support of Wits Health Consortium (WHC), a wholly owned company of Wits. The Consortium collectively has a long track record in the fields of vaccinology, public health medicine, clinical trials, research, technology transfer, project management and health economics. This entity will coordinate the project, ensuring a synergistic outcome between the components of drug discovery/research and manufacture. It will also drive the strategic and operational direction. This will be accomplished by engaging with stakeholders and public health experts and academics to ensure that the company moves forward in a sustainable, Afro-centric manner, rooted in public good. Please visit Rubic's website at http://www.rubicconsortium.co.za for additional information.

About Dyadic International, Inc.

Dyadic International, Inc. is a global biotechnology company that is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1. The C1 microorganism, which enables the development and large-scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles (VLPs) and antigens, monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Certain other research activities are ongoing, which include the exploration of using C1 to develop and produce certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. As the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs, and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and improve access and cost to patients and the healthcare system, but most importantly save lives.

Please visit Dyadic's website at http://www.dyadic.com for additional information, including details regarding Dyadic's plans for its biopharmaceutical business.

Safe Harbor Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are forward-looking. Examples of forward-looking statements include, but are not limited to, statements regarding Dyadic's expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance. Forward-looking statements generally can be identified by use of the words expect, should, intend, aim, anticipate, believe, will, project, may, might, potential, pursue, or continue and other similar terms or variations of them or similar terminology. However, not all forward-looking statements contain these words. Actual events or results may differ materially from those in the forward-looking statements because of various important factors, including (1) general economic, political and market conditions; (2) our ability to generate the required productivity, stability, purity, performance, cost, safety and other data necessary to carry out and implement our biopharmaceutical research and business plans and strategic initiatives; (3) our ability to implement and successfully carry out Dyadics and third parties research and development efforts; (4) the pharmaceutical and biotech industry, governmental regulatory and other agencies willingness to adopt, utilize and approve the use of the C1 gene expression platform; and (5) other factors described in the Company's most recent filings with the SEC. Given these risks and uncertainties, you should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this press release are made only as of the date hereof, and Dyadic does not intend, and except as required by law assumes no obligation to update publicly any such forward-looking statements, whether because of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled "Risk Factors" in Dyadic's annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission (the SEC), as such factors may be updated from time to time in Dyadic's periodic filings with the SEC, which are accessible on the SEC's website and http://www.dyadic.com.

Contact:

Dyadic International, Inc.Ping W. RawsonChief Financial OfficerPhone: (561) 743-8333Email: prawson@dyadic.com

Rubic Consortium (Pty) LtdDr. Julian NaidooDirectorEmail: jnaidoo@witshealth.co.za; julian@rubic.co.za

Read this article:

Dyadic Announces Technology Transfer and Licensing Agreement With South Africas Rubic Consortium Aiming to Develop and Commercialize Vaccines for...

Rawlings this month released its new REV1X series of baseball gloves, which it says were "secretly" developed for years

ST. LOUIS About three years ago, Rawlings Sporting Goods began to think about how it might be able to develop a new type of baseball glove using cutting-edge technology.

The Town & Country-based sports equipment manufacturer soon found its blueprint for the project thanks to a conversation with New York Mets shortstop Francisco Lindor. The four-time All-Star and two-time Gold Glove Award winner wanted a glove that would keep the thumb and the pinky of his glove stiff while also having a soft pocket to trap the baseball.

Once we identified the problem withFrancisco Lindor, then we really had a target," saidRyan Farrar, senior director of ball gloves at Rawlings.

Rawlings this month released its new REV1X series of baseball gloves, which it says were "secretly" developed for years and both inspired by and designed with help from Lindor. The REV1X takes a swing at using 3D printing technology for baseball gloves to offer what Rawlings says is better playability and durability. The REV1X gloves include 3D-printed lattice inserts for the thumb and pinky designed to provide a stiffer feel, a laceless web and heel, and a molded 3D design on the glove back. Rawlings teamed up with 3D printing technology company Carbon and digital manufacturer Fast Radius to develop the glove, which retails for $399.

TheBusiness Journalcaught up with Farrar to discuss the new glove and the companys innovation process. The conversation has been edited for length and clarity.

How did you strategize the development of this new series of gloves? Once the problem was identified, we went to the drawing board with our engineers. We had confines of what we could work in. We knew we needed to make a glove that was different, but also traditional in feel and play of a ball glove. There were certain things we knew we couldnt touch. We started with, We can mess with these, we cant mess with these. For example, leather lace, leather palm, leather web all the places where you need the leather so the ball broke in we didnt touch. Then we said, What can we touch? We knew we needed to look at the padding. We know we can mess with the back of the glove. We know we can mess with the end sides of the glove and how it goes along the wrist. We literally just wrote those on a board and just started attacking each one.

How did you keep the consumer in mind while developing the glove? The first thing is the price point. We knew starting out we couldnt, even given technology, come out with a $1,000 baseball glove and be like, "Here it is. Were Rawlings, take it or leave it. The market above $279, $359, $399, $500, it shrinks dramatically. The price point was super important to us because we are believers in this technology. We wanted to make sure that high school kids had the opportunity to go out and use this high-end glove the same as the pro guys do. It does you no good to make this REV1X that is only for pro players. If you have something, you want to make sure its attainable for 13- to 18-year-old baseball players. We met a lot and talked to a lot of customers and consumers about the ceiling of where this could be.

Why is innovation needed for the baseball glove? A lot of people would think there aren't too many ways to tinker with a baseball glove.Thats been the mindset for a very long time. It really hasnt evolved or there hasnt been some serious innovation in quite some time. The one thing about the REV1X that is unique in the Carbon pieces is the playability, consistently. It starts out stiffer than padding and then what happens when your glove starts to break in is that padding starts to get soft whereas that Carbon padding has consistent playability throughout the life cycle of the product. Its super important you know your glove is going to perform like it did yesterday throughout the life. Thats not to say felt and wool are not for gloves. They are very good for gloves and have been used for gloves for a long time. They are the two best materials for it, but the consistent playability for the REV1X is probably the easiest I would explain to someone for it.

Click here for the full story.

Read more from the original source:

Why Rawlings thinks it built a better baseball glove using 3D printing technology - KSDK.com

RICHARDSON, Texas--(BUSINESS WIRE)--Mavenir the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects today announced the appointment of Bejoy Pankajakshan to the newly created role of Chief Technology and Strategy Officer (CTSO). An expansion of Bejoys previous role at Mavenir as Executive Vice President, Chief Strategy Officer (CSO), Bejoy will power Mavenirs leadership in innovation and support the companys vision to deliver a single software-based network that runs on any cloud.

We welcome Bejoy into this new role at a time of rapid growth and market success that is driving innovation and advanced technology solutions for our customers, says Mavenir President and Chief Executive Officer Pardeep Kohli. Over the last three years, since his appointment as CSO, he has been pivotal to Mavenirs strategy, investment and M&A activities while providing impeccable technology and product leadership. This noteworthy appointment further solidifies Bejoys role in leading the formulation and execution of the company strategy.

Bejoys extensive mobile and telecommunications experience spans more than 2 decades, and includes leadership positions in product and technology development, strategic planning, M&A transactions, competitive analysis, network engineering and design. With a formidable track record driving engagement with engineering, R&D teams, senior management and Board members, he has the unique ability to design complex technical solutions that align to the business vision while championing future technology innovation, strategic planning, market forecasting and competitive trend analysis to accelerate digital transformation. In addition to leading multiple industry-first innovations and launches of world-first technologies both from the operator and vendor side, Bejoy holds more than 30 patents covering next-generation technologies. A member of the Harvard Business School Advanced Management Program class of 2022, he earned an MS from Southern Methodist University and an MBA from Kansas State University.

As CTSO, Bejoy will focus on setting and developing a coherent architecture direction in partnership with different business units, accelerating the cross-functional alignment of Mavenirs product portfolio that delivers and creates a path for future technology innovation. He will also manage Mavenirs standards body participation and patents pool.

This is not only an extraordinary opportunity but also a great honor to lead Mavenir in technology and strategy, says Bejoy. Today, with a rapidly growing team, Mavenir has achieved remarkable milestones for both the company and its global customers. I cannot think of a more important and exciting time to take on such a significant new role. I welcome new challenges and look forward to helping Mavenir realize our bold vision.

In this expanded role as CTSO, we look forward to Bejoy playing a key role in the technology alignment both with other Siris companies as well as the Koch companies, given the recent $500M investment in Mavenir, said Hubert de Pesquidoux, executive chairman of Mavenir and Executive Partner at Siris Capital.

About Mavenir

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industrys only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the worlds subscribers. For information about Mavenir, visit: http://www.mavenir.com.

Follow this link:

Mavenir Appoints Bejoy Pankajakshan to Newly Created Role of Chief Technology and Strategy Officer - Business Wire

Most solar panels covering the worlds rooftops, fields, and deserts today share the same ingredient: crystalline silicon. The material, made from raw polysilicon, is shaped into wafers and wired into solar cells, devices that convert sunlight into electricity. Recently, the industrys dependence on this singular technology has become something of a liability. Supply chain bottlenecks are slowing down new solar installations worldwide. Major polysilicon suppliers in Chinas Xinjiang region accused of using forced labor from Uyghurs are facing U.S. trade sanctions.

Fortunately, crystalline silicon isnt the only material that can help harness the suns energy. In the United States, scientists and manufacturers are working to expand production of cadmium telluride solar technology. Cadmium telluride is a type of thin film solar cell, and, as that name suggests, its much thinner than a traditional silicon cell. Today, panels using cadmium telluride supply about 40 percent of the U.S. utility-scale market, and about 5 percent of the global solar market. And they stand to benefit from the headwinds facing the broader solar industry.

Its a very volatile time, especially for the crystalline silicon supply chain in general, said Kelsey Goss, a solar research analyst for the energy consultancy group Wood Mackenzie. Theres great potential for cadmium telluride manufacturers to take more market share in the coming year. Especially, she noted, since the cadmium telluride sector is already scaling up.

In June, the solar manufacturer First Solar said it would invest $680 million in a third cadmium telluride solar factory in northwest Ohio. When the facility is finished, in 2025, the company will be able to make 6 gigawatts worth of solar panels in the area. Thats enough to power roughly 1 million American homes. Another Ohio-based solar firm, Toledo Solar, recently entered the market and is making cadmium telluride panels for residential rooftops. And in June, the U.S. Department of Energy and its National Renewable Energy Laboratory, or NREL, launched a $20 million program to accelerate research and grow the supply chain for cadmium telluride. One of the goals of the program is to help insulate the U.S. solar market from global supply constraints.

Researchers at NREL and First Solar, previously called Solar Cell Inc., have worked together since the early 1990s to develop cadmium telluride technology. Cadmium and telluride are byproducts of smelting zinc ores and refining copper, respectively. Whereas silicon wafers are wired together to make cells, cadmium and telluride are applied as a thin layer about one-tenth of the diameter of a human hair to a pane of glass, along with other electricity-conducting materials. First Solar, now the worlds largest thin film manufacturer, has supplied panels for solar installations in 45 countries.

The technology has certain advantages over crystalline silicon, said NREL scientist Lorelle Mansfield. For instance, the thin film process requires fewer materials than the wafer-based approach. Thin film technology is also well-suited for use in flexible panels, like ones that cover backpacks or drones or are integrated into building faades and windows. Importantly, the thin film panels perform better in hot temperatures, while silicon panels can overheat and become less efficient at generating electricity, she said.

But crystalline silicon has the upper hand in other areas, such as their average efficiency meaning the percentage of sunlight that panels absorb and convert into electricity. Historically, silicon panels have had higher efficiencies than cadmium telluride technology, though the gap is narrowing.Todays industrially produced silicon panels can achieve efficiencies of 18 to 22 percent, while First Solar has reported an average efficiency of 18 percent for its newest commercial panels.

Still, the main reason silicon has dominated the global market is relatively simple. It all comes down to the cost, Goss said. The solar market tends to be highly driven by the cheapest technology.

Crystalline silicon costs about $0.24 to $0.25 to produce each watt of solar power, which is less than other contenders, she said. First Solar said it no longer reports the cost-per-watt to produce its cadmium telluride panels, only that costs have declined significantly since 2015 when the company reported costs of $0.46 per watt and continue to drop every year. There are a few reasons for silicons relative cheapness. The raw material polysilicon, which is also used in computers and smartphones, is more widely available and inexpensive than supplies of cadmium and telluride. As factories for silicon panels and related components have scaled up, the overall costs of making and installing the technology have declined. The Chinese government has also heavily supported and subsidized the countrys silicon solar sector so much so that about 80 percent of the worlds solar manufacturing supply chain now runs through China.

Falling panel costs have driven the global solar boom. Over the last decade, the worlds total installed solar capacity has seen a nearly tenfold increase, from about 74,000 megawatts in 2011 to nearly 714,000 megawatts in 2020, according to the International Renewable Energy Agency. The United States accounts for about one-seventh of the worlds total, and solar is now one of the largest sources of new electricity capacity installed in the U.S. every year.

The cost per watt of cadmium telluride and other thin film technologies is similarly expected to shrink as manufacturing expands. (First Solar says that when its new Ohio facility opens, the company will deliver the lowest cost per watt on the entire solar market.) But cost isnt the only metric that matters, as the industrys current supply chain issues and labor concerns make clear.

Mark Widmar, CEO of First Solar, said the companys planned $680 million expansion is part of a larger effort to build a self-sufficient supply chain and decouple the U.S. solar industry from China. Although cadmium telluride panels dont use any polysilicon, First Solar has felt other challenges facing the industry, like pandemic-induced backlogs in the maritime shipping industry. In April, First Solar told investors that congestion at American ports was holding up panel shipments from its facilities in Asia. Increasing U.S. production will allow the company to use roads and railways to ship its panels, not cargo ships, Widmar said. And the companys existing recycling program for its solar panels allows it to reuse materials many times over, further reducing its reliance on foreign supply chains and raw materials.

As First Solar churns out panels, scientists at both the company and NREL continue to test and improve cadmium telluride technology. In 2019, the partners developed a new approach that involves doping the thin film materials with copper and chlorine to achieve even higher efficiencies. Earlier this month, NREL announced the results of a 25-year field test at its outdoor facility in Golden, Colorado. A 12-panel array of cadmium telluride panels was operating at 88 percent of its original efficiency, a strong result for a panel thats sat outside for over two decades. The degradation is in line with what silicon systems do, according to the NREL release.

Mansfield, the NREL scientist, said the goal isnt to replace crystalline silicon with cadmium telluride or establish one technology as superior to the other. I think theres a place for all of them in the market, and they each have their applications, she said. We want all energy to go to renewable sources, so we really need all of these different types of technology to meet that challenge.

Read more here:

A different kind of solar technology is poised to go big - Grist

DUBLIN, July 27, 2021 /PRNewswire/ -- The "3D Printing Market Research Report , by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global 3D Printing Market size was estimated at USD 14.93 Billion in 2020 and expected to reach USD 17.57 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 18.01% to reach USD 40.33 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the 3D Printing to forecast the revenues and analyze the trends in each of the following sub-markets:

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the 3D Printing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global 3D Printing Market, including 3D Systems, Inc., ARC Group Worldwide, Inc., Beijing Tiertime Technology Co., Ltd., Carbon, Inc., EnvisionTEC, EOS GmbH, ExOne Company, General Electric Company, Groupe Gorge Company, Hewlett-Packard Development Company, L.P., Hoganas AB, Koninklijke DSM N.V., Materialise NV, Mcor Technologies Ltd, Nano Dimension, Optomec Inc., Proto Labs, Ltd., Renishaw PLC, SLM Solutions Group AG, Stratasys, Ltd., taulman3D, LLC, Ultimaker BV, and voxeljet AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global 3D Printing Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global 3D Printing Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global 3D Printing Market?4. What is the competitive strategic window for opportunities in the Global 3D Printing Market?5. What are the technology trends and regulatory frameworks in the Global 3D Printing Market?6. What is the market share of the leading vendors in the Global 3D Printing Market?7. What modes and strategic moves are considered suitable for entering the Global 3D Printing Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary3.1. Introduction3.2. Market Outlook3.3. Geography Outlook3.4. Competitor Outlook

4. Market Overview4.1. Introduction4.2. Cumulative Impact of COVID-19

5. Market Insights5.1. Market Dynamics5.1.1. Drivers5.1.1.1. Increased investments in 3D printing by start-up companies5.1.1.2. Rising deployment into various industry verticals5.1.1.3. 3D printing in construction medical implants and underwater printing5.1.2. Restraints5.1.2.1. Lack of standardization5.1.3. Opportunities5.1.3.1. Emerging applications in printed electronics, education, and jewelry5.1.3.2. Need of technology in post-processing systems5.1.4. Challenges5.1.4.1. High cost of materials and ensuring product quality5.2. Porters Five Forces Analysis5.2.1. Threat of New Entrants5.2.2. Threat of Substitutes5.2.3. Bargaining Power of Customers5.2.4. Bargaining Power of Suppliers5.2.5. Industry Rivalry

6. Americas 3D Printing Market6.1. Introduction6.2. Argentina6.3. Brazil6.4. Canada6.5. Mexico6.6. United States

7. Asia-Pacific 3D Printing Market7.1. Introduction7.2. Australia7.3. China7.4. India7.5. Indonesia7.6. Japan7.7. Malaysia7.8. Philippines7.9. Singapore7.10. South Korea7.11. Thailand

8. Europe, Middle East & Africa 3D Printing Market8.1. Introduction8.2. France8.3. Germany8.4. Italy8.5. Netherlands8.6. Qatar8.7. Russia8.8. Saudi Arabia8.9. South Africa8.10. Spain8.11. United Arab Emirates8.12. United Kingdom

9. Competitive Landscape9.1. FPNV Positioning Matrix9.1.1. Quadrants9.1.2. Business Strategy9.1.3. Product Satisfaction9.2. Market Ranking Analysis9.3. Market Share Analysis, By Key Player9.4. Competitive Scenario9.4.1. Merger & Acquisition9.4.2. Agreement, Collaboration, & Partnership9.4.3. New Product Launch & Enhancement9.4.4. Investment & Funding9.4.5. Award, Recognition, & Expansion

10. Company Usability Profiles10.1. 3D Systems, Inc.10.2. ARC Group Worldwide, Inc.10.3. Beijing Tiertime Technology Co., Ltd.10.4. Carbon, Inc.10.5. EnvisionTEC10.6. EOS GmbH10.7. ExOne Company10.8. General Electric Company10.9. Groupe Gorge Company10.10. Hewlett-Packard Development Company, L.P.10.11. Hoganas AB10.12. Koninklijke DSM N.V.10.13. Materialise NV10.14. Mcor Technologies Ltd10.15. Nano Dimension10.16. Optomec Inc.10.17. Proto Labs, Ltd.10.18. Renishaw PLC10.19. SLM Solutions Group AG10.20. Stratasys, Ltd.10.21. taulman3D, LLC10.22. Ultimaker BV10.23. voxeljet AG

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/rba76d

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the rest here:

Worldwide 3D Printing Industry to 2026 - Need of Technology in Post-Processing Systems Presents Opportunities - PRNewswire